Cmp Dev Llc Drug Patent Portfolio
Cmp Dev Llc owns 6 orange book drugs protected by 23 US patents with Potassium Phosphates having the least patent protection, holding only 1 patent. And Carospir with maximum patent protection, holding 8 patents. Given below is the list of Cmp Dev Llc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11253474 | Pharmaceutical solution of amlodipine | 24 Feb, 2041 | Active |
| US11458095 | Pharmaceutical solution of amlodipine | 24 Feb, 2041 | Active |
| US11723866 | Pharmaceutical solution of amlodipine | 24 Feb, 2041 | Active |
| US12005141 | Pharmaceutical solution of amlodipine | 24 Feb, 2041 | Active |
| US10632150 | Potassium phosphates composition for injection | 19 Apr, 2039 | Active |
| US11337979 | Liquid oral formulations for sildenafil | 24 Dec, 2038 | Active |
| US11464778 | Liquid oral formulations for sildenafil | 24 Dec, 2038 | Active |
| US11759468 | Liquid oral formulations for sildenafil | 24 Dec, 2038 | Active |
| US12005062 | Liquid oral formulations for sildenafil | 24 Dec, 2038 | Active |
| US11382917 | Liquid oral formulations for tadalafil | 24 Dec, 2038 | Active |
| US11666576 | Liquid oral formulations for tadalafil | 24 Dec, 2038 | Active |
| US11975006 | Liquid oral formulations for tadalafil | 24 Dec, 2038 | Active |
| US11369567 | Aqueous suspension suitable for oral administration | 07 Jun, 2037 | Active |
| US11654106 | Aqueous suspension suitable for oral administration | 07 Jun, 2037 | Active |
| US11925704 | Aqueous suspension suitable for oral administration | 07 Jun, 2037 | Active |
| US10493083 | Spironolactone aqueous compositions | 28 Oct, 2036 | Active |
| US10624906 | Spironolactone aqueous compositions | 28 Oct, 2036 | Active |
| US10660907 | Spironolactone aqueous compositions | 28 Oct, 2036 | Active |
| US10888570 | Spironolactone aqueous compositions | 28 Oct, 2036 | Active |
| US11389461 | Spironolactone aqueous compositions | 28 Oct, 2036 | Active |
| US11395828 | Spironolactone aqueous compositions | 28 Oct, 2036 | Active |
| US11491166 | Spironolactone aqueous compositions | 28 Oct, 2036 | Active |
| US9757394 | Spironolactone aqueous formulations | 28 Oct, 2036 | Active |
Latest Legal Activities on Cmp Dev Llc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cmp Dev Llc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 26 Jun, 2024 | US10888570 |
|
Recordation of Patent Grant Mailed
Critical
| 12 Mar, 2024 | US11925704 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Mar, 2024 | US11925704 |
| Recordation of Patent eGrant | 12 Mar, 2024 | US11925704 |
| Patent eGrant Notification | 12 Mar, 2024 | US11925704 |
| Mail Patent eGrant Notification | 12 Mar, 2024 | US11925704 |
|
Email Notification
Critical
| 12 Mar, 2024 | US11925704 |
|
Email Notification
Critical
| 22 Feb, 2024 | US11925704 |
|
Issue Notification Mailed
Critical
| 21 Feb, 2024 | US11925704 |
| Dispatch to FDC | 08 Feb, 2024 | US11925704 |
|
Application Is Considered Ready for Issue
Critical
| 08 Feb, 2024 | US11925704 |
|
Issue Fee Payment Verified
Critical
| 30 Jan, 2024 | US11925704 |
| Response to Reasons for Allowance | 30 Jan, 2024 | US11925704 |
|
Issue Fee Payment Received
Critical
| 30 Jan, 2024 | US11925704 |
|
Email Notification
Critical
| 09 Nov, 2023 | US11925704 |
Cmp Dev Llc's Family Patents
Cmp Dev Llc Drug List
Given below is the complete list of Cmp Dev Llc's drugs and the patents protecting them.
1. Atorvaliq
Atorvaliq is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11369567 | Aqueous suspension suitable for oral administration |
07 Jun, 2037
(12 years from now)
| Active |
| US11654106 | Aqueous suspension suitable for oral administration |
07 Jun, 2037
(12 years from now)
| Active |
| US11925704 | Aqueous suspension suitable for oral administration |
07 Jun, 2037
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Atorvaliq's drug page
2. Carospir
Carospir is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10493083 | Spironolactone aqueous compositions |
28 Oct, 2036
(11 years from now)
| Active |
| US10624906 | Spironolactone aqueous compositions |
28 Oct, 2036
(11 years from now)
| Active |
| US10660907 | Spironolactone aqueous compositions |
28 Oct, 2036
(11 years from now)
| Active |
| US10888570 | Spironolactone aqueous compositions |
28 Oct, 2036
(11 years from now)
| Active |
| US11389461 | Spironolactone aqueous compositions |
28 Oct, 2036
(11 years from now)
| Active |
| US11395828 | Spironolactone aqueous compositions |
28 Oct, 2036
(11 years from now)
| Active |
| US11491166 | Spironolactone aqueous compositions |
28 Oct, 2036
(11 years from now)
| Active |
| US9757394 | Spironolactone aqueous formulations |
28 Oct, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Carospir's drug page
3. Liqrev
Liqrev is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11337979 | Liquid oral formulations for sildenafil |
24 Dec, 2038
(13 years from now)
| Active |
| US11464778 | Liquid oral formulations for sildenafil |
24 Dec, 2038
(13 years from now)
| Active |
| US11759468 | Liquid oral formulations for sildenafil |
24 Dec, 2038
(13 years from now)
| Active |
| US12005062 | Liquid oral formulations for sildenafil |
24 Dec, 2038
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Liqrev's drug page
4. Norliqva
Norliqva is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11253474 | Pharmaceutical solution of amlodipine |
24 Feb, 2041
(16 years from now)
| Active |
| US11458095 | Pharmaceutical solution of amlodipine |
24 Feb, 2041
(16 years from now)
| Active |
| US11723866 | Pharmaceutical solution of amlodipine |
24 Feb, 2041
(16 years from now)
| Active |
| US12005141 | Pharmaceutical solution of amlodipine |
24 Feb, 2041
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Norliqva's drug page
5. Potassium Phosphates
Potassium Phosphates is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10632150 | Potassium phosphates composition for injection |
19 Apr, 2039
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Potassium Phosphates's drug page
Explore Our Curated Drug Screens
6. Tadliq
Tadliq is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11382917 | Liquid oral formulations for tadalafil |
24 Dec, 2038
(13 years from now)
| Active |
| US11666576 | Liquid oral formulations for tadalafil |
24 Dec, 2038
(13 years from now)
| Active |
| US11975006 | Liquid oral formulations for tadalafil |
24 Dec, 2038
(13 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tadliq's drug page